Company Filing History:
Years Active: 1980-1986
Title: David Collard: Innovator in Pharmaceutical Chemistry
Introduction
David Collard is a notable inventor based in Beckenham, GB. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that have therapeutic applications. With a total of 5 patents to his name, Collard's work has the potential to impact medical treatments significantly.
Latest Patents
Among his latest patents, Collard has developed compounds that utilize 3-(arylmethyleneamino)-1-aryl-2-pyrazolines for prophylactic purposes. These compounds inhibit both the cyclo-oxygenase and lipoxygenase pathways of arachidonic acid oxygenation, making them useful in medicine as anti-inflammatory and anti-asthmatic agents. The compounds can be administered either as raw chemicals or in association with a carrier as a pharmaceutical formulation. Additionally, he has worked on anti-inflammatory pyrazole thioureas, which share similar therapeutic applications and preparation methods.
Career Highlights
David Collard is associated with Burroughs Wellcome Co., where he has been instrumental in advancing pharmaceutical research. His innovative approaches to drug formulation and development have garnered attention in the scientific community. His work exemplifies the intersection of chemistry and medicine, showcasing how innovative compounds can lead to improved health outcomes.
Collaborations
Collard has collaborated with notable colleagues, including Frederick C Copp and Peter T Roberts. These partnerships have likely contributed to the success of his research and the development of his patented compounds.
Conclusion
David Collard's contributions to pharmaceutical chemistry through his patents and collaborations highlight his role as an innovator in the field. His work continues to pave the way for advancements in medical treatments.